Morning Movers 7/29: INO, ELRN, CNO, VPHM, WCG, BDN Higher; THQI, EHTH, ALVR, PERY, RSYS Lower

July 29, 2009 9:55 AM EDT

Inovio Biomedical Corporation (NYSE: INO) 190% HIGHER; announced that the company's SynCon H1N1 influenza DNA vaccines achieved protection against current circulating swine origin influenza A/H1N1 viruses in animal studies. Click here for the full report.

Elron Electronic Industries Ltd. (NASDAQ: ELRN) 36% HIGHER; announced today, that further to it previous announcement on July 28, 2009, Medingo Ltd., a group company held 92% by Elron and its subsidiary, RDC - Rafael Development Corporation Ltd., has received formal clearance from the FDA, to market its Solo(TM) MicroPump Insulin Delivery System in the United States. Click here for the full report.

Conseco, Inc. (NYSE: CNO) 23.2% HIGHER; announced preliminary Q2 net income of $86.7 million which was up 47% from last year. Net operating income per diluted share was $0.22, up 69% from last year. Net income per diluted share in the range of 9 cents to 15 cents, compared to a net loss per diluted share of $2.65 in 2Q08.

ViroPharma Inc. (Nasdaq: VPHM) 21.3% HIGHER; reported Q2 EPS of $0.20, or adjusted EPS of $0.38, well above the consensus of $0.18. Revenuse came in at $81.9 million, versus the consensus of $75.5 million. ViroPharma sees 2009 CINRYZE net sales of $80-$95 million.

WellCare Health Plans, Inc. (NYSE: WCG) 20.1% HIGHER; reports Q2 EPS of $1.42, ex-items, versus the analyst estimate of $0.40. Revenue for the quarter was $1.8 billion, versus the consensus of $1.77 billion. Sees FY09 EPS of $2.75-$2.95, versus the consensus of $2.07, and sales of $6.75-$6.85 billion, versus the Street estimate of $6.9 billion.

THQ (Nasdaq: THQI) 17.4% LOWER; reports Q1 EPS of $0.10 ex-items, 18 cents better than the analyst estimate of ($0.08). Revenue for the quarter was $243.5 million, versus the consensus of $203 million. Sees 2010 sales above 2009. Expects to achieve profitability in FY10. Sees Q2 sales $85M to $95M versus consensus $123.3 million.

Brandywine Realty Trust (NYSE: BDN) 14.9% HIGHER; reports Q2 FFO of $0.56 vs. consensus of $0.36. Revenues were $145.9 million vs. $144.17 million consensus. Based on current plans and assumptions and subject to the risks and uncertainties more fully described in our Securities and Exchange Commission filings, we are increasing our previously issued guidance for full year 2009 FFO per diluted share to be in a range of $1.75 to $1.80 versus the prior guidance of $1.60 to $1.74 including impairment charges in both instances. (Consensus is $1.71)

eHealth, Inc. (NASDAQ: EHTH) 14.9% LOWER; reports Q2 EPS of $0.19, ex-items, 5 cents better than the analyst estimate of $0.14. Revenue for the quarter was $33.4 million, versus the consensus of $34.10 million.

eFuture Information Technology Inc. (Nasdaq: EFUT) 14.8% HIGHER; announced that it has entered into a strategic relationship with Microsoft Corporation (Nasdaq: MSFT) to provide a standardized POS-ERP system for retailers in China. This system will integrate Microsoft Windows Embedded POSReady 2009 into eFuture's POS-ERP Store Operation System.

Semitool (Nasdaq: SMTL) 13.1% HIGHER; reports Q2 loss of $0.05, 2 cents better than the analyst estimate of ($0.07). Revenue for the quarter was $31.8 million, versus the consensus of $32.35 million. Sees Q4 EPS 2c to 5c versus consensus of a loss of 4 cents. Sees Q4 $40M to $42M versus consensus of $34.9M.

Alvarion Ltd. (Nasdaq: ALVR) 12.5% LOWER; reports Q2 loss of $0.01, better than the analyst estimate of a $0.05 loss. Revenue for the quarter was $58.7 million, versus the consensus of $58.2 million.

Perry Ellis Int'l (Nasdaq: PERY) 12.4% LOWER; SunTrust downgrades the stock from Buy to Neutral.

RadiSys Corporation (Nasdaq: RSYS) 12.3% LOWER; reports Q2 EPS of $0.21, 9 cents better than the analyst estimate of $0.12. Revenue for the quarter was $78.1 million, versus the consensus of $74.95 million. Sees Q3 EPS 2c to 8c versus consensus of 16 cents. Sees Q3 revenues $67M to $73M versus $78 million. Cutting 119 jobs.

Kulicke & Soffa (Nasdaq: KLIC) 12% HIGHER; reports Q2 EPS of ($0.20), 9 cents better than the analyst estimate of ($0.29). Revenue for the quarter was $52.1 million, versus the consensus of $42.60 million.

MEDTOX Scientific, Inc. (Nasdaq: MTOX) 11.1% HIGHER; received 510(k) clearance from the FDA to market its PROFILE(r)-V MEDTOXScan(r) Drugs-of-Abuse Test System with three additional drugs -- Oxycodone, Propoxyphene and Tricyclic Anitidepressants.

The Timken Company (NYSE: TKR) 10.7% LOWER; reports a Q2 loss of $0.21 vs. consensus for $0.12 loss. Revenues were $828.9 million vs. $878.45 million consensus. As a result of the company's global market outlook, it reduced its earnings estimate for 2009, now expecting earnings per share, excluding special items, to be a loss of $(0.40) to $(0.90). The company remains on track to deliver strong cash from operations in 2009, driven by effective working capital management and reduced spending. (FY-09 EPS consensus is $0.04 profit)

Tegal Corporation, (Nasdaq: TGAL) 10.6% HIGHER; launched ProNova(TM), the company's third-generation high-density Inductively Coupled Plasma reactor for Tegal DRIE Series Wafer Processing Products. Targeted for fast-growing MEMS and 3D IC applications, delivery of the ProNova has already begun, with the first order going to a new Tegal customer in the EU (see related announcement).

Penn National Gaming, Inc. (Nasdaq: PENN) 10.3% LOWER; reports Q2 adj-EPS of $0.32, 4 cents lower than the analyst estimate of $0.36. Revenue for the quarter was $580.8 million, versus the consensus of $594.51 million. Sees Q3 sales of about $651.4 million, versus the consensus of $639.65 million, with GAAP EPS of about $0.35, which compares to the Street estimate of $0.38. Raises its FY09 sales guidance from $2.478 billion to $2.463 billion, versus the consensus of $2.46 billion. EPS for the year lowered from $1.38 to $1.28, which compares to the Street estimate of $1.45.

Wright Express Corporation (NYSE: WXS) 9.8% HIGHER; reports Q2 EPS of $0.57, ex-items, 17 cents better than the analyst estimate of $0.40. Revenue for the quarter was $78.6 million, versus the consensus of $74.51 million. Sees Q3 sales of $78-$83 million, versus the consensus of $79.35 million, with adj-EPS of $0.54-$0.59, which compares to the Street estimate of $0.44. For FY09, sales are expected to be in the range of $300-$310 million, versus the consensus of $299.40 million. EPS for the year are expected to be $1.94-$2.04, versus the Street estimate of $1.68.

Royal Caribbean Cruises Ltd. (NYSE: RCL) 9.6% LOWER; reports Q2 loss of $0.16 (including $0.05 per share from the impact of the H1N1 virus and approximately $0.11 from non-operating expenses related to foreign exchange adjustments and hedging ineffectiveness), 3 cents lower than the analyst estimate of ($0.13) and compared to a gain of $0.40 in the same quarter last year. Revenue for the quarter was $1.3 billion, versus the consensus of $1.36 billion. Sees Q3 EPS of $0.95-$1.00, versus the consensus of $1.22. EPS for FY09 are expected to be in the range of $0.70-$0.80, which compares to the Street estimate of $0.94.

Superior Energy Services (NYSE: SPN) 9.4% LOWER; reports Q2 EPS of $0.35, versus the analyst estimate of $0.44. Revenue for the quarter was $361.2 million, versus the consensus of $392.31 million.

McKesson Corporation (NYSE: MCK) 8.9% HIGHER; reports Q1 EPS of $1.06, 20 cents better than the analyst estimate of $0.86. Revenue for the quarter was $26.7 billion, versus the consensus of $26.78 billion. Raises FY10 EPS to $4.15-$4.30, versus the consensus of $3.99. Upgraded to Outperform at Baird.

MDRNA (Nasdaq: MRNA) 8.3% HIGHER; started at Buy at Cantor Fitzgerald. The firm said MDRNA was poised to open higher. It did.

To get this report daily, visit http://www.streetinsider.com/entities/Morning+Movers.

Related Categories

Special Reports

Stocks Mentioned

Related Entities

• Cantor Fitzgerald
• Robert W Baird
• StreetInsider.com Morning Movers

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?